Householder Group Estate & Retirement Specialist’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1K Sell
9
-969
-99% -$136K ﹤0.01% 501
2024
Q3
$152K Sell
978
-5
-0.5% -$807 0.04% 298
2024
Q2
$153K Buy
983
+137
+16% +$20.6K 0.04% 279
2024
Q1
$115K Buy
846
+57
+7% +$7.55K 0.03% 324
2023
Q4
$106K Hold
789
0.03% 326
2023
Q3
$107K Buy
+789
New +$108K 0.04% 304
2023
Q1
$114K Buy
821
+3
+0.4% +$404 0.04% 281
2022
Q4
$110K Sell
818
-6
-0.7% -$752 0.16% 68
2022
Q3
$90K Buy
+824
New +$105K 0.04% 291

Other funds holding AZN

Householder Group Estate & Retirement Specialist's AZN Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its AstraZeneca (AZN) stake by 99% in Q4 2024, selling an estimated $136K and leaving 9 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

Householder Group Estate & Retirement Specialist first reported a position in AZN in Q3 2022 and has held it in 9 quarters since. The position peaked at $153K in Q2 2024. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 9 shares of AstraZeneca worth $1K as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 969 AstraZeneca shares in Q4 2024, an estimated $136K.
  • AstraZeneca made up ﹤0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #501 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in AstraZeneca in Q3 2022 and has held it in 9 quarters since.
  • Householder Group Estate & Retirement Specialist's AstraZeneca position peaked at $153K in Q2 2024.
  • 1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.